NCT05833035View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1291583 is Processed in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions
Healthy
Interventions
DRUG

BI 1291583 mixed with [C-14] BI 1291583

BI 1291583 mixed with \[C-14\] BI 1291583

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05833035 - A Study in Healthy Men to Test How BI 1291583 is Processed in the Body | Biotech Hunter | Biotech Hunter